ConductScience.org, home

Paper39005483

CURE: A deep learning framework pre-trained on large-scale patient data for treatment effect estimation.

Liu R and 2 others. Patterns (N Y), 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. CURE: A deep learning framework pre-trained on large-scale patient data for treatment effect estimation. Papers, record 39005483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39005483

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CURE: A deep learning framework pre-trained on large-scale patient data for treatment effect estimation.
PubMed
Journal
Patterns (N Y)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.61, provisional
iCite
Revised in PubMed
2026-09-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu RRuoqi
2Chen PYPin-Yu
3Zhang PPing

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 GM141279NIGMS NIH HHSUnited StatesR01GM141279PubMed

Source NIH RePORTER

Download CSV of grants

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132346050BEHRT: Transformer for Electronic Health Records.Sci Rep2020https://conductscience.org/library/papers/32346050PubMed
234758252Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.N Engl J Med2021https://conductscience.org/library/papers/34758252PubMed
326994063Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.Am J Epidemiol2016https://conductscience.org/library/papers/26994063PubMed
434017034Med-BERT: pretrained contextualized embeddings on large-scale structured electronic health records for disease prediction.NPJ Digit Med2021https://conductscience.org/library/papers/34017034PubMed
523297653Causal inference in public health.Annu Rev Public Health2013https://conductscience.org/library/papers/23297653PubMed
632160801Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.Circulation2020https://conductscience.org/library/papers/32160801PubMed
735603127A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data.Nat Mach Intell2021https://conductscience.org/library/papers/35603127PubMed
830770453Metalearners for estimating heterogeneous treatment effects using machine learning.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/30770453PubMed
910738049Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.N Engl J Med2000https://conductscience.org/library/papers/10738049PubMed
1039005483CURE: A deep learning framework pre-trained on large-scale patient data for treatment effect estimation.Patterns (N Y)2024https://conductscience.org/library/papers/39005483PubMed
1125390318Randomised controlled trials for Ebola: practical and ethical issues.Lancet2014https://conductscience.org/library/papers/25390318PubMed
1215026432A definition of causal effect for epidemiological research.J Epidemiol Community Health2004https://conductscience.org/library/papers/15026432PubMed
1321870978Apixaban versus warfarin in patients with atrial fibrillation.N Engl J Med2011https://conductscience.org/library/papers/21870978PubMed
149468688Understanding controlled trials. Why are randomised controlled trials important?BMJ1998https://conductscience.org/library/papers/9468688PubMed
1531750899Ticagrelor monotherapy versus aspirin in patients undergoing multiple arterial or single arterial coronary artery bypass grafting: insights from the TiCAB trial.Eur J Cardiothorac Surg2020https://conductscience.org/library/papers/31750899PubMed
1629132880Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.Lancet2018https://conductscience.org/library/papers/29132880PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
39760722Artificial intelligence and stroke imaging.Curr Opin Neurol2025https://conductscience.org/library/papers/39760722PubMed
39060569AI and RCTs.Br Dent J2024https://conductscience.org/library/papers/39060569PubMed
39005493Large pre-trained models for treatment effect estimation: Are we there yet?Patterns (N Y)2024https://conductscience.org/library/papers/39005493PubMed
39005483CURE: A deep learning framework pre-trained on large-scale patient data for treatment effect estimation.Patterns (N Y)2024https://conductscience.org/library/papers/39005483PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39005483

GET https://conductscience.org/api/papers/v1/39005483/authors